Literature DB >> 11800585

Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity.

R Nirmala1, P R Narayanan, R Mathew, M Maran, C N Deivanayagam.   

Abstract

SETTING: A study was undertaken to understand the non-major histocompatibility restricted cytotoxicity in order to delineate the role of natural killer (NK) cells towards the development of host immunity to tuberculosis.
OBJECTIVE: (a) Enumeration of NK cell numbers and activity in normal individuals (35), pulmonary tuberculosis patients (32), HIV-infected TB patients (20) and patient contacts (10), (b) effect of treatment on NK status, (c) enumeration of effector-target conjugates and (d) effect of in vitro cytokine stimulation on NK activity.
DESIGN: NK cells were enumerated by flow cytometry. NK activity was assessed by chromium release assay before and after treatment for tuberculosis and after stimulation with IL-2/IL-12. Novel flow cytometric method was standardized to enumerate effector-target conjugates.
RESULTS: No changes were seen between different groups as far as number of NK cells and relative proportions of different conjugate types were concerned, but there was a decrease in NK activity in TB patients which increased after treatment. Augmentation of NK activity was observed after cytokine stimulation.
CONCLUSION: Lowered NK activity during tuberculosis infection is probably the 'effect' and not the 'cause' for the disease as demonstrated by the follow-up study. Similar number of conjugates in both groups indicates no defect in the recognition/binding step but probably at subsequent steps of the cytotoxic process. Augmentation of NK activity with cytokines implicates them as potential adjuncts to tuberculosis chemotherapy. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800585     DOI: 10.1054/tube.2001.0309

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

1.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 2.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

3.  Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-role of exogenous interleukins.

Authors:  P V Ramana Rao; S Ramanavelan; S Rajasekaran; Alamelu Raja
Journal:  J Clin Immunol       Date:  2010-03-13       Impact factor: 8.317

4.  NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.

Authors:  Pablo Schierloh; Mercedes Alemán; Noemí Yokobori; Leandro Alves; Nicolás Roldán; Eduardo Abbate; María del C Sasiain; Silvia de la Barrera
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

5.  Phosphoantigen-Stimulated γδ T Cells Suppress Natural Killer-Cell Responses to Missing-Self.

Authors:  Katherine Walwyn-Brown; Jason Pugh; Alexander T H Cocker; Niassan Beyzaie; Bernhard B Singer; Daniel Olive; Lisbeth A Guethlein; Peter Parham; Zakia Djaoud
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

6.  Cellular immune response to pulmonary infections in HIV-infected individuals hospitalized with diverse grades of immunosuppression.

Authors:  M J Miguez-Burbano; D Ashkin; A Rodriguez; R Duncan; M Flores; B Acosta; N Quintero; A Pitchenik
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

7.  Lymphocyte subpopulations in pulmonary tuberculosis patients.

Authors:  Figen Deveci; H Handan Akbulut; Ilhami Celik; M Hamdi Muz; Fulya Ilhan
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 8.  Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.

Authors:  Jonathan Kevin Sia; Maria Georgieva; Jyothi Rengarajan
Journal:  J Immunol Res       Date:  2015-07-14       Impact factor: 4.818

9.  Distinct Human NK Cell Phenotypes and Functional Responses to Mycobacterium tuberculosis in Adults From TB Endemic and Non-endemic Regions.

Authors:  Levelle D Harris; Jeremiah Khayumbi; Joshua Ongalo; Loren E Sasser; Joan Tonui; Angela Campbell; Felix Hayara Odhiambo; Samuel Gurrion Ouma; Galit Alter; Neel R Gandhi; Cheryl L Day
Journal:  Front Cell Infect Microbiol       Date:  2020-03-24       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.